Retrieve available abstracts of 12 articles: HTML format
Single Articles
April 2025
SU H, Jin X, Kong L, You Y, et al The triage role of cytological DNA methylation in women with non-16/18,
specifically genotyping high-risk HPV infection.
Br J Cancer. 2025 Apr 10. doi: 10.1038/s41416-025-03005. PubMedAbstract available
October 2024
HIRAHARA Y, Shimizu K, Yamasaki S, Iyoda T, et al Crucial immunological roles of the invasion front in innate and adaptive immunity
in cervical cancer.
Br J Cancer. 2024 Oct 29. doi: 10.1038/s41416-024-02877. PubMedAbstract available
May 2024
REBOLJ M, Brentnall AR, Cuschieri K Predictable changes in the accuracy of human papillomavirus tests after
vaccination: review with implications for performance monitoring in cervical
screening.
Br J Cancer. 2024;130:1733-1743. PubMedAbstract available
April 2024
PORTNOY A, Pedersen K, Kim JJ, Burger EA, et al Vaccination and screening strategies to accelerate cervical cancer elimination in
Norway: a model-based analysis.
Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02682. PubMedAbstract available
January 2024
WANG Y, He M, He T, Ouyang X, et al Integrated genomic and transcriptomic analysis reveals the activation of PI3K
signaling pathway in HPV-independent cervical cancers.
Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555. PubMedAbstract available
November 2023
DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a
systematic literature review and meta-analysis.
Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490. PubMedAbstract available
August 2023
CUSCHIERI K, Palmer T, Graham C, Cameron R, et al The changing nature of HPV associated with high grade cervical lesions in
vaccinated populations, a retrospective study of over 1700 cases in Scotland.
Br J Cancer. 2023 Aug 10. doi: 10.1038/s41416-023-02386. PubMedAbstract available
July 2023
KERRISON RS, Jones A, Peng J, Price G, et al Inequalities in cancer screening participation between adults with and without
severe mental illness: results from a cross-sectional analysis of primary care
data on English Screening Programmes.
Br J Cancer. 2023;129:81-93. PubMedAbstract available
April 2023
VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive
self-collected samples from primary HPV-based screening.
Br J Cancer. 2023 Apr 26:1-8. doi: 10.1038/s41416-023-02277. PubMedAbstract available
KAMAL M, Lameiras S, Deloger M, Morel A, et al Correction to: Human papilloma virus (HPV) integration signature in Cervical
Cancer: identification of MACROD2 gene as HPV hot spot integration site.
Br J Cancer. 2023 Apr 13. doi: 10.1038/s41416-023-02261. PubMed
March 2023
MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al Detection of circulating cell-free HPV DNA of 13 HPV types for patients with
cervical cancer as potential biomarker to monitor therapy response and to detect
relapse.
Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233. PubMedAbstract available
GILHAM C, Sargent A, Crosbie EJ, Peto J, et al Long-term risks of invasive cervical cancer following HPV infection: follow-up of
two screening cohorts in Manchester.
Br J Cancer. 2023 Mar 23. doi: 10.1038/s41416-023-02227. PubMedAbstract available